4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001654954-20-011925
Chief Executive Officer acquired 4,628 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nijhawan Pardeep Chief Executive Officer | 2020-11-05 | Option exercise | +4,628 | $4.00 | $18,512 | 2,128,652 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Nijhawan Pardeep Chief Executive Officer | 2020-11-05 | Option exercise · Common share warrants (Right to buy) | −4,628 | 0 | I: show line 2 in the form |
Loading xslF345X03/section16.xml…